PATENT CLAIM ANALYSIS

Application Number: 16023313
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "653000"]

Abstract:
The present invention is directed to epinephrine spray formulations. The present invention is further directed to methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatments.

Claim (Index 12):
The formulation of  claim 10 , wherein the formulation provides a pharmacokinetic parameter selected from the group consisting of a C max  of about 419 picograms per milliliter, a T max  of about 0.41 hours, an AUC last  of about 596 h*pg/mL, an AUC inf  of about 727 h*pg/mL and a combination thereof.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 94.0
- Lexical Diversity: 1.54545
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15488712', '15876553', '15601331', '15246343', '14923630']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8134775278061761
- 35 USC 102 Novelty (BERT): 0.543458491419556
- Combined Prediction Score: 0.7864756241675142
- Mean Citation Score: 293.91530200000005
- Max Citation Score: 411.79935
- Similarity Product: 271.117499096337

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test